Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Expert Opinion on Biological Therapy|October 15, 2011
Tumor-specific allogeneic cells for cancer therapyAssaf Marcus, Zelig EshharExpert Opinion on Biological Therapy|March 26, 2014
Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancerAssaf Marcus, Zelig EshharBlood|June 10, 2011
Redirected tumor-specific allogeneic T cells for universal treatment of cancerAssaf Marcus, Tova Waks, Zelig EshharCurrent Opinion in Molecular Therapeutics|February 9, 2010
Adoptive cancer immunotherapy using genetically engineered designer T-cells: First steps into the clinicZelig EshharAnnual Review of Pharmacology and Toxicology|January 8, 2016
Therapeutic Potential of T Cell Chimeric Antigen Receptors (CARs) in Cancer Treatment: Counteracting Off-Tumor Toxicities for Safe CAR T Cell TherapyGideon Gross, Zelig EshharDiscovery Medicine|August 14, 2010
Redirecting immune cells against bone metastases: Immunotherapy of prostate cancer metastases using genetically programmed immune effector cellsZelig Eshhar, Tova Waks, Jehonathan PinthusCancer Journal (Sudbury, Mass.)|March 27, 2014
The emergence of T-bodies/CAR T cellsZelig Eshhar, Tova Waks, Gideon GrossGastroenterology|April 22, 2008
Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in miceEran Elinav, Tova Waks, Zelig EshharMolecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2014
Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cellsAnat Globerson-Levin, Tova Waks, Zelig EshharOncoimmunology|December 18, 2012
CAR's made it to the pancreasMarkus Chmielewski, Amit Maliar, Zelig Eshhar, et al.Pageof 5